- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
According to our latest study, the global Transcriptomics market size was valued at USD 3884.5 million in 2022 and is forecast to a readjusted size of USD 7365.1 million by 2029 with a CAGR of 9.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
This report is a detailed and comprehensive analysis for global Transcriptomics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Transcriptomics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Transcriptomics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Transcriptomics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Transcriptomics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcriptomics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcriptomics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies and Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Transcriptomics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PCR
Microarray
Sequencing
Market segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Market segment by players, this report covers
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transcriptomics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transcriptomics, with revenue, gross margin and global market share of Transcriptomics from 2018 to 2023.
Chapter 3, the Transcriptomics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Transcriptomics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Transcriptomics.
Chapter 13, to describe Transcriptomics research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Transcriptomics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Transcriptomics by Type
1.3.1 Overview: Global Transcriptomics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Transcriptomics Consumption Value Market Share by Type in 2022
1.3.3 PCR
1.3.4 Microarray
1.3.5 Sequencing
1.4 Global Transcriptomics Market by Application
1.4.1 Overview: Global Transcriptomics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical and Biotechnology
1.4.3 Academic Research and Government Institutes
1.4.4 Hospitals and Diagnostic Centers
1.5 Global Transcriptomics Market Size & Forecast
1.6 Global Transcriptomics Market Size and Forecast by Region
1.6.1 Global Transcriptomics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Transcriptomics Market Size by Region, (2018-2029)
1.6.3 North America Transcriptomics Market Size and Prospect (2018-2029)
1.6.4 Europe Transcriptomics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Transcriptomics Market Size and Prospect (2018-2029)
1.6.6 South America Transcriptomics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Transcriptomics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Transcriptomics Product and Solutions
2.1.4 Thermo Fisher Scientific Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Transcriptomics Product and Solutions
2.2.4 Illumina Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Recent Developments and Future Plans
2.3 QIAGEN (Exiqon)
2.3.1 QIAGEN (Exiqon) Details
2.3.2 QIAGEN (Exiqon) Major Business
2.3.3 QIAGEN (Exiqon) Transcriptomics Product and Solutions
2.3.4 QIAGEN (Exiqon) Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 QIAGEN (Exiqon) Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Transcriptomics Product and Solutions
2.4.4 Agilent Technologies Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Transcriptomics Product and Solutions
2.5.4 Roche Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Roche Recent Developments and Future Plans
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Transcriptomics Product and Solutions
2.6.4 GE Healthcare Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GE Healthcare Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Transcriptomics Product and Solutions
2.7.4 Bio-Rad Laboratories Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 Fluidigm
2.8.1 Fluidigm Details
2.8.2 Fluidigm Major Business
2.8.3 Fluidigm Transcriptomics Product and Solutions
2.8.4 Fluidigm Transcriptomics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fluidigm Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transcriptomics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Transcriptomics by Company Revenue
3.2.2 Top 3 Transcriptomics Players Market Share in 2022
3.2.3 Top 6 Transcriptomics Players Market Share in 2022
3.3 Transcriptomics Market: Overall Company Footprint Analysis
3.3.1 Transcriptomics Market: Region Footprint
3.3.2 Transcriptomics Market: Company Product Type Footprint
3.3.3 Transcriptomics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Transcriptomics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Transcriptomics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Transcriptomics Consumption Value Market Share by Application (2018-2023)
5.2 Global Transcriptomics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Transcriptomics Consumption Value by Type (2018-2029)
6.2 North America Transcriptomics Consumption Value by Application (2018-2029)
6.3 North America Transcriptomics Market Size by Country
6.3.1 North America Transcriptomics Consumption Value by Country (2018-2029)
6.3.2 United States Transcriptomics Market Size and Forecast (2018-2029)
6.3.3 Canada Transcriptomics Market Size and Forecast (2018-2029)
6.3.4 Mexico Transcriptomics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Transcriptomics Consumption Value by Type (2018-2029)
7.2 Europe Transcriptomics Consumption Value by Application (2018-2029)
7.3 Europe Transcriptomics Market Size by Country
7.3.1 Europe Transcriptomics Consumption Value by Country (2018-2029)
7.3.2 Germany Transcriptomics Market Size and Forecast (2018-2029)
7.3.3 France Transcriptomics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Transcriptomics Market Size and Forecast (2018-2029)
7.3.5 Russia Transcriptomics Market Size and Forecast (2018-2029)
7.3.6 Italy Transcriptomics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Transcriptomics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Transcriptomics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Transcriptomics Market Size by Region
8.3.1 Asia-Pacific Transcriptomics Consumption Value by Region (2018-2029)
8.3.2 China Transcriptomics Market Size and Forecast (2018-2029)
8.3.3 Japan Transcriptomics Market Size and Forecast (2018-2029)
8.3.4 South Korea Transcriptomics Market Size and Forecast (2018-2029)
8.3.5 India Transcriptomics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Transcriptomics Market Size and Forecast (2018-2029)
8.3.7 Australia Transcriptomics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Transcriptomics Consumption Value by Type (2018-2029)
9.2 South America Transcriptomics Consumption Value by Application (2018-2029)
9.3 South America Transcriptomics Market Size by Country
9.3.1 South America Transcriptomics Consumption Value by Country (2018-2029)
9.3.2 Brazil Transcriptomics Market Size and Forecast (2018-2029)
9.3.3 Argentina Transcriptomics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Transcriptomics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Transcriptomics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Transcriptomics Market Size by Country
10.3.1 Middle East & Africa Transcriptomics Consumption Value by Country (2018-2029)
10.3.2 Turkey Transcriptomics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Transcriptomics Market Size and Forecast (2018-2029)
10.3.4 UAE Transcriptomics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Transcriptomics Market Drivers
11.2 Transcriptomics Market Restraints
11.3 Transcriptomics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Transcriptomics Industry Chain
12.2 Transcriptomics Upstream Analysis
12.3 Transcriptomics Midstream Analysis
12.4 Transcriptomics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Transcriptomics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Transcriptomics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Transcriptomics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Transcriptomics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Transcriptomics Product and Solutions
Table 8. Thermo Fisher Scientific Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Illumina Company Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina Transcriptomics Product and Solutions
Table 13. Illumina Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina Recent Developments and Future Plans
Table 15. QIAGEN (Exiqon) Company Information, Head Office, and Major Competitors
Table 16. QIAGEN (Exiqon) Major Business
Table 17. QIAGEN (Exiqon) Transcriptomics Product and Solutions
Table 18. QIAGEN (Exiqon) Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. QIAGEN (Exiqon) Recent Developments and Future Plans
Table 20. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 21. Agilent Technologies Major Business
Table 22. Agilent Technologies Transcriptomics Product and Solutions
Table 23. Agilent Technologies Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Agilent Technologies Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Transcriptomics Product and Solutions
Table 28. Roche Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Roche Recent Developments and Future Plans
Table 30. GE Healthcare Company Information, Head Office, and Major Competitors
Table 31. GE Healthcare Major Business
Table 32. GE Healthcare Transcriptomics Product and Solutions
Table 33. GE Healthcare Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. GE Healthcare Recent Developments and Future Plans
Table 35. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 36. Bio-Rad Laboratories Major Business
Table 37. Bio-Rad Laboratories Transcriptomics Product and Solutions
Table 38. Bio-Rad Laboratories Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Bio-Rad Laboratories Recent Developments and Future Plans
Table 40. Fluidigm Company Information, Head Office, and Major Competitors
Table 41. Fluidigm Major Business
Table 42. Fluidigm Transcriptomics Product and Solutions
Table 43. Fluidigm Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Fluidigm Recent Developments and Future Plans
Table 45. Global Transcriptomics Revenue (USD Million) by Players (2018-2023)
Table 46. Global Transcriptomics Revenue Share by Players (2018-2023)
Table 47. Breakdown of Transcriptomics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Transcriptomics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key Transcriptomics Players
Table 50. Transcriptomics Market: Company Product Type Footprint
Table 51. Transcriptomics Market: Company Product Application Footprint
Table 52. Transcriptomics New Market Entrants and Barriers to Market Entry
Table 53. Transcriptomics Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Transcriptomics Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global Transcriptomics Consumption Value Share by Type (2018-2023)
Table 56. Global Transcriptomics Consumption Value Forecast by Type (2024-2029)
Table 57. Global Transcriptomics Consumption Value by Application (2018-2023)
Table 58. Global Transcriptomics Consumption Value Forecast by Application (2024-2029)
Table 59. North America Transcriptomics Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America Transcriptomics Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America Transcriptomics Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America Transcriptomics Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America Transcriptomics Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America Transcriptomics Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe Transcriptomics Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe Transcriptomics Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe Transcriptomics Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe Transcriptomics Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe Transcriptomics Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Transcriptomics Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Transcriptomics Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific Transcriptomics Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific Transcriptomics Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific Transcriptomics Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific Transcriptomics Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific Transcriptomics Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America Transcriptomics Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America Transcriptomics Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America Transcriptomics Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America Transcriptomics Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America Transcriptomics Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America Transcriptomics Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa Transcriptomics Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa Transcriptomics Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa Transcriptomics Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa Transcriptomics Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa Transcriptomics Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa Transcriptomics Consumption Value by Country (2024-2029) & (USD Million)
Table 89. Transcriptomics Raw Material
Table 90. Key Suppliers of Transcriptomics Raw Materials
List of Figures
Figure 1. Transcriptomics Picture
Figure 2. Global Transcriptomics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Transcriptomics Consumption Value Market Share by Type in 2022
Figure 4. PCR
Figure 5. Microarray
Figure 6. Sequencing
Figure 7. Global Transcriptomics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Transcriptomics Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical and Biotechnology Picture
Figure 10. Academic Research and Government Institutes Picture
Figure 11. Hospitals and Diagnostic Centers Picture
Figure 12. Global Transcriptomics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Transcriptomics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Transcriptomics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Transcriptomics Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Transcriptomics Consumption Value Market Share by Region in 2022
Figure 17. North America Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Transcriptomics Revenue Share by Players in 2022
Figure 23. Transcriptomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Transcriptomics Market Share in 2022
Figure 25. Global Top 6 Players Transcriptomics Market Share in 2022
Figure 26. Global Transcriptomics Consumption Value Share by Type (2018-2023)
Figure 27. Global Transcriptomics Market Share Forecast by Type (2024-2029)
Figure 28. Global Transcriptomics Consumption Value Share by Application (2018-2023)
Figure 29. Global Transcriptomics Market Share Forecast by Application (2024-2029)
Figure 30. North America Transcriptomics Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Transcriptomics Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Transcriptomics Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Transcriptomics Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Transcriptomics Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Transcriptomics Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 40. France Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Transcriptomics Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Transcriptomics Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Transcriptomics Consumption Value Market Share by Region (2018-2029)
Figure 47. China Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 50. India Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Transcriptomics Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Transcriptomics Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Transcriptomics Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Transcriptomics Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Transcriptomics Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Transcriptomics Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Transcriptomics Consumption Value (2018-2029) & (USD Million)
Figure 64. Transcriptomics Market Drivers
Figure 65. Transcriptomics Market Restraints
Figure 66. Transcriptomics Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Transcriptomics in 2022
Figure 69. Manufacturing Process Analysis of Transcriptomics
Figure 70. Transcriptomics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
